10.24.25 -- Trust But Verify: Validating AI In Pharma's GxP World

In this webinar, experts will explore strategies to improve drug candidate success rates by integrating robust formulation development and predictive preclinical models. Learn how comprehensive drug characterization, in vitro/ex vivo testing, and systematic formulation approaches can identify promising candidates early, reduce development risks, and align with evolving regulatory expectations to streamline development and improve overall therapeutic outcomes. Click here to learn more.

If you’re launching an international clinical trial, consider the noteworthy benefits of partnering with an in-country depot, including increased efficiency, reduced costs, and reliable access to raw materials.

In your CDMO search, prioritize finding a partner who recognizes impurity control as a critical component of patient-focused drug development and offers the necessary capabilities to ensure it.

Insights and case studies demonstrate how a tailored, stepwise testing approach can effectively detect, quantify, and control nitrosamine impurities while maintaining cost efficiency.

In 2022, we had headlines such as: FDA Declares Nationwide Amoxicillin Shortage. Now three years later, a homegrown manufacturer — USAntibiotics of Bristol, Tennessee — says it can cover America’s demand under a new arrangement with two titans of distribution and retail: McKesson and Walmart. The other “titan” in the deal is President Trump.

Watch as speakers delve into the intricacies of formulation maps for amorphous solid dispersions (ASDs) and the key criteria for salt screening, which are essential in early-phase screening for enabled forms.

Steven Facer and Laxxon Medical COO Klaus Kühne describe the capabilities of 3D screen printing for pharmaceutical production. Explore prototyping, IP protection, release profile possibilities, and more.

Significant interest has been focused on the science of scale for spray drying. Gain insight into critical steps that can smooth the development pathway, eliminating scale-up headaches down the road.

The HERMA 552C bottom labeler is a compact and versatile solution for applying labels to the underside of products, eliminating unnecessary work and minimizing setup times.

Consider three new solutions that improve tablet quality, reduce setup time, and protect your equipment for more efficient tablet manufacturing — presented by a seasoned expert in tooling and tablets.

From early-phase IND-enabling studies to late-stage development and full commercialization, we provide support tailored to the needs of emerging biotechs and established pharma companies.